More Potential: For Communities & Our People
More Potential: For Communities & Our People
Search
More Health: For People & Animals
More Health: For People & Animals
More Potential: Overview
Society continues to face challenges ranging from health to education, work prospects, living conditions, inequalities and poverty, often impacting vulnerable communities the most.
More Green
More Green
Women in STEM: Passion for science to achieve more sustainable healthcare solutions
Women in STEM: Passion for science to achieve more sustainable healthcare solutions
Our Commitment
Humanity faces great challenges. We believe that we can always do more - for ourselves and for future generations.
We are there for our patients – even in crisis regions.
We are there for our patients – even in crisis regions.
Always Here – Our Commitment for Ukraine
Boehringer Ingelheim has actively supported Ukrainian civilians throughout the Russian invasion.
Transforming pig farming: how AI helps detect respiratory disease in pigs and more
Transforming pig farming: how AI helps detect respiratory disease in pigs and more
More Health: Overview
As a company that operates at the intersection of human and veterinary medicine, we have unique opportunities to advocate for disadvantaged populations.
The global $1 trillion mental health problem needs more funding
Nearly one billion people around the world live with a mental health condition, yet an estimated 70% don’t have access to the help they need.
More Green Overview
Our pillar MORE GREEN encompasses environmental initiatives that consider many different aspects.
Our innovation strategy
Our Innovation Strategy at Boehringer Ingelheim in Research and Development
Thank you for submitting your report
multistep form
Our FOCUS
Our FOCUS
Embracing diversity in clinical trials: A global mandate
Have you ever wondered why medicines work differently for different people? Each patient is unique. By embracing diversity in clinical trials, we enable more equitable and inclusive healthcare.
Pride Month: Colleagues from the LGBTQIA+ community and allies share their views on our culture of respect
In June, as the world celebrates Pride Month, we asked three of our colleagues to share their thoughts on the significance of respect at our company.
Who we are
The Boehringer Ingelheim Regional Center Vienna (RCV for short) bears business responsibility for more than 30 countries in Central and Eastern Europe and Central Asia.
Open Innovation Boehringer Ingelheim
Learn more about how we’re working across the innovation community to advance research and accelerate the development of new medicines
Innovation in Oncology and Cancer Immunology Research
We are taking a diligent and broad approach, creating a collaborative research network to tap into a diversity of minds, which is vital in addressing some of the most challenging, but potentially most impactful, areas of cancer research.
Venture Fund searching for groundbreaking trends
The Boehringer Ingelheim Venture Fund acquires minority stakes in biotech start-ups, and even supports the majority before and during their founding.
Our Responsibility
Human Health Our Responsibility
Boehringer Ingelheim Office Hours 2024: Shaping the Future of Innovation in Europe
Boehringer Ingelheim is actively supporting the next generation of innovators.
Boehringer Ingelheim Austria - Value through Innovation
Boehringer Ingelheim is one of the world's top 20 pharmaceutical companies with over 130 years of experience.
Living and Working in Times of War - Employees from Ukraine Report
Living and Working in Times of War - Employees from Ukraine Report